Your first week on Wegovy: what actually happens

The 0.25 mg starting dose is a tolerability dose: its job is to let your system adjust, not to produce weight loss yet.
Side effects in week one are usually gastrointestinal (nausea, mild stomach upset, loose stools) and tend to settle as your body adapts.
Most people feel some appetite change in the first fortnight, though noticeable weight loss typically takes longer to show on the scales.
Semaglutide works by activating GLP-1 receptors involved in hunger signalling and gastric emptying, effects that build gradually over weeks.

The first week on Wegovy is mostly about your body getting used to something new. Most people receive 0.25 mg as a starter dose — a level chosen for tolerability, not yet for weight loss — and many notice little beyond mild nausea or a slightly earlier sense of fullness at meals. It is a prescription-only medicine, so a prescriber will have assessed whether it is right for you before you start. Wegovy (semaglutide) is a once-weekly injection licensed in the UK for weight management in adults, and week one is simply the beginning of a gradual process that takes months to show its full effect.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A week-by-week look at starting Wegovy: symptoms, appetite and what is normal

You've just done your first injection, here is what the next seven days often look like

You've pressed the pen against your thigh or abdomen, heard the click, and now you're wondering what's supposed to happen. For most people: not very much, not yet. The 0.25 mg dose is calibrated to ease your system into treatment rather than hit it hard. A small number of people feel almost nothing different in week one. Others notice nausea within a few hours of the first injection, usually mild and brief, sometimes arriving the day after rather than immediately. If you want a detailed walkthrough of what to expect as each day unfolds, our guide to Wegovy week 1 covers the timeline in full.

Gastrointestinal reactions are the most commonly reported effects at the start. Nausea tops the list, followed by loose stools, constipation (the two can alternate in the same person), indigestion and burping. These are well-documented in clinical data and described on the NHS's semaglutide medicines page. The reassuring pattern is that symptoms tied to a new dose tend to peak around day two or three and ease off as the week continues. Eating smaller meals, avoiding rich or fatty food, and staying well hydrated all help. Timing your injection for an evening or weekend when you can rest if needed is a practical adjustment many people find useful.

Fatigue and mild headache can also appear in the first week. These are not dangerous, they reflect the body adjusting to slower gastric emptying and, possibly, a subtle shift in calorie intake. If symptoms feel genuinely severe or you vomit repeatedly and cannot keep fluids down, contact your prescriber or the aftercare team. That is not the expected experience, and it is worth flagging early.

Will you feel less hungry in the first week?

Some people notice it almost immediately. Meals feel satisfying with less on the plate. The urge to snack in the evening quietens a little. Others feel no appetite change in week one at all, and that is equally normal. Semaglutide's effect on hunger builds gradually as the drug reaches a steady concentration; at 0.25 mg you are at the floor of the therapeutic range, so dramatic appetite suppression this early is not guaranteed and not the goal.

What you are more likely to notice is a small shift in how quickly you feel full rather than a wholesale loss of interest in food. Pay attention to that signal, it is the mechanism working as it should. Eating slowly and stopping when you are comfortably full (rather than when the plate is empty) will serve you well throughout treatment, not just this week. How long Wegovy takes to work meaningfully is a longer conversation, but the foundations are laid in these early weeks.

One thing our clinical team hears regularly: people worry that because they don't feel much in week one, the treatment isn't working for them. That worry is understandable, and it almost always turns out to be unfounded. The dose escalation schedule exists precisely because the medicine needs time, and your body needs time alongside it.

What week one does not tell you about your results

The STEP 1 trial, which established the evidence base for Wegovy 2.4 mg, ran for 68 weeks and found an average body weight reduction of around 15% at the maintenance dose, as published in the New England Journal of Medicine. Week one contributes almost nothing to that figure on its own. The weight-loss trajectory is strongly back-weighted: results accumulate through the titration phase and beyond as the dose rises and appetite suppression deepens.

Some people do see a small movement on the scales in the first fortnight, partly water, partly a mild calorie reduction from eating a little less. Do not read too much into it either way. A week one without visible scale movement is not a sign of failure; a small early drop does not predict your eventual outcome. Both are within the normal range. What to expect after a full month on Wegovy gives a more useful early benchmark than the first week alone.

It is also worth knowing that how your first week feels does not reliably predict long-term tolerability. People who feel quite nauseous in week one often find the next few weeks considerably easier, as the body adapts. The gradual dose steps (0.25 mg, then 0.5 mg, then 1.0 mg and so on) are designed to make that adaptation as smooth as possible. You can read about what shifts as the weeks progress on the week two page and, for a fuller picture of the early months, week four is when many people start to feel a more settled pattern. There is genuinely no rush.

If you are still deciding whether to start, or want to understand more about your eligibility, checking your eligibility with our prescribers costs nothing and carries no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions